查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1726122

美国生物分析测试服务市场规模、份额、趋势分析报告：按分子、测试、工作流程、最终用途和细分市场预测，2025-2030 年

U.S. Bioanalytical Testing Services Market Size, Share & Trends Analysis Report By Molecule (Small Molecule, Large Molecule), By Test, By Workflow, By End-use (Pharma & BioPharma Companies, CDMO, CRO), And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

市场规模和趋势

预计 2024 年美国生物分析测试服务市场规模将达到 19.8 亿美元，2025 年至 2030 年的复合年增长率将达到 9.33%。

美国生物分析测试服务产业的成长受到多种因素的推动，例如药物开发和核准流程的增加、对生技药品、生物相似药和基因治疗的需求不断增长以及测试服务外包的增加。此外，严格的 FDA 法规也推动了对严格生物分析测试的需求。此外，生物分析测试设施的扩建也是推动市场成长的关键方面。

一些工业和生物製药公司正在大力投资升级和扩展其测试基础设施，以满足对先进生物分析服务日益增长的需求。此外，复杂生技药品、生物相似药、基因疗法和个人化医疗发展的激增推动了对先进测试平台的需求，以执行复杂的生物分析，如药物动力学、生物标记发现和免疫抗原性评估。

此外，一些服务供应商已经开发出整合高解析度质谱 (HRMS)、NGS 和自动化技术的最先进的设施，以提供更快、更准确、更具成本效益的生物分析测试，进一步促进发展。例如，2024年9月，美国实验室控股公司宣布完成其位于待开发区的实验室的扩建。此次扩展旨在支持罕见疾病、肿瘤学和其他治疗领域的先进疗法（包括细胞和基因疗法）的临床前和临床分子分析检测服务的开发和检验。此次扩张为公司带来了竞争优势。

加强监管控制和对生物分析测试重要性的认识是推动生物分析测试服务市场成长的主要因素。随着美国FDA 和 EMA 等多个监管机构推出严格的药物开发指南，特别是在药物动力学、动态和生物等效性测试方面，外包趋势日益增长。这些指南强调需要准确可靠的生物分析方法来提高新药和生物相似药的安全性和有效性。例如，美国FDA的生物分析方法验证指南为方法开发、验证和样品分析提供了明确的标准，并推动製药公司寻求合约服务供应商的专业知识。此外，市场参与企业透过提供先进的分析平台和标准化通讯协定来帮助发起人遵守监管要求，从而推动市场需求。

同样，技术进步和不断增长的研发投入也是推动美国生物分析测试服务产业成长的关键因素。高性能组织筛检(HTS)、液相层析法-质谱 (LC-MS) 和次世代定序 (NGS) 等创新技术的不断发展，显着提高了生物分析测试的准确性、速度和灵敏度。这些技术创新正在帮助服务供应商执行更复杂的测试，并获得有关药物疗效、安全性、药物动力学等的准确数据。此外，自动化和人工智慧 (AI) 融入生物分析工作流程简化了流程、减少了人为错误并提高了吞吐量。预计这些因素将在预计的时间内推动市场发展。

目录

第一章调查方法与范围

第二章执行摘要

第三章美国生物分析测试服务市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/支持市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 投资金筹措视角
  • 临床试验量分析（2024年）
    • 各地区临床试验总数（2024年）
    • 各阶段临床试验总数（2024 年）
    • 依研究设计分類的临床试验总数（2024 年）
    • 按主要治疗领域分類的临床试验总数（2024年）
  • 定价模式分析
  • 科技
  • 法律规范
  • 市场分析工具
    • 波特五力分析
    • PESTEL 与 SWOT 分析
    • COVID-19影响分析

第四章美国生物分析测试服务市场：分子、估计和趋势分析

  • 美国生物分析测试服务市场（按分子）：细分仪表板
  • 美国生物分析测试服务市场（按分子）：变异分析
  • 依分子分类，2018-2030
  • 小分子
  • 高分子
    • 液相层析质谱研究
    • 免疫检测
    • 其他大分子检测

第五章美国生物分析测试服务市场：测试、估计和趋势分析

  • 美国生物分析测试服务市场（按测试）：细分仪表板
  • 美国生物分析测试服务市场（按测试）：变异分析
  • 2018-2030 年测试
  • ADME
    • 体内
    • 体外
  • 药物动力学（PK）
  • 动态（PD）
  • 生物有效性
  • 生物等效性
  • 生物标记检测
  • 基于细胞的检测
  • 病毒检测
  • 其他的

第六章美国生物分析测试服务市场：工作流程、估计和趋势分析

  • 美国生物分析测试服务市场（按工作流程）：细分仪表板
  • 美国生物分析测试服务市场（按工作流程）：变异分析
  • 按工作流程，2018-2030
  • 样品采集和製备
    • 样本的采集、处理和储存
    • 蛋白质沉淀
    • 液-液萃取
    • 固相萃取
    • 其他的
  • 方法开发和检验
  • 样品分析
    • 连字符技术
    • 层析法技术
    • 电泳
    • 配体结合试验
    • 质谱法
    • 光谱技术
    • 基因组和分子技术
  • 其他的

第七章美国生物分析测试服务市场最终用途、预测与趋势分析

  • 美国生物分析测试服务市场（按最终用途）：细分仪表板
  • 美国生物分析测试服务市场（依最终用途）：变异分析
  • 按应用，2018-2030 年
  • 製药和生物製药公司
  • CDMO
  • 执行长（CRO）
  • 其他的

第八章 竞争态势

  • 市场参与企业分类
  • 2024 年公司市场占有率/估值分析
  • 公司简介
    • Thermo Fisher Scientific, Inc.
    • ICON plc
    • Charles River Laboratories International, Inc.
    • Laboratory Corporation of America Holdings.
    • IQVIA Inc.
    • Syneos Health
    • SGS SA
    • Intertek Group Plc
    • Pace Analytical Services, LLC
    • Medpace Holdings, Inc.
    • North America Science Associates Inc.（NAMSA）
Product Code: GVR-4-68040-292-0

Market Size & Trends:

The U.S. bioanalytical testing services market size was estimated at USD 1.98 billion in 2024 and is expected to grow at a CAGR of 9.33% from 2025 to 2030. The growth of the U.S. bioanalytical testing services industry is driven by several factors, such as the rising drug development and approval process, growing demand for biologics, biosimilars, and gene therapies, and rising outsourcing of testing services. In addition, Stringent FDA regulations are driving the need for precise bioanalytical testing. Furthermore, the expansion of bioanalytical testing facilities is another key aspect driving the market growth.

Several industry players and biopharmaceutical companies are investing significantly to upgrade and expand their testing infrastructure to meet the growing demand for advanced bioanalytical services. Moreover, a surge in the number of complex biologics, biosimilars, gene therapies, and personalized medicine development is further creating the need for sophisticated testing platforms to perform complex bioanalyses, such as pharmacokinetics, biomarker discovery, and immunogenicity assessments.

Moreover, several service providers are developing state-of-the-art facilities integrated with high-resolution mass spectrometry (HRMS), NGS, and automation technologies to offer faster, more accurate, and cost-effective bioanalytical testing, further propelling market progression. For instance, in September 2024, Laboratory Corporation of America Holdings announced the completion expansion of its laboratory in Greenfield. The expansion aimed to o support the development and validation of preclinical and clinical molecular bioanalytical testing services for advanced therapies, including cell and gene therapies for rare diseases, oncology, and other therapeutic areas. This expansion offered a competitive advantage to the firm.

Increasing regulatory control and awareness regarding the importance of bioanalytical testing are key factors propelling the growth of the bioanalytical testing service market. The introduction of stringent guidelines on drug development, particularly in pharmacokinetics, pharmacodynamics, and bioequivalence testing by several regulatory agencies, such as the U.S. FDA and EMA, leads to a rising preference for outsourcing. These guidelines highlight the need for precise and reliable bioanalytical methods to enhance the safety and efficacy of new drugs & biosimilars. For instance, the U.S. FDA's Bioanalytical Method Validation Guidance provides clear standards for method development, validation, and sample analysis, which have driven pharmaceutical companies to seek specialized expertise from contract service providers. Moreover, the market participants assist sponsors in complying with regulatory requirements by offering advanced analytical platforms and standardized protocols, driving market demand.

Likewise, technological advancements and growing R&D investments are key factors driving the U.S. bioanalytical testing service industry growth. The continuous developments of innovative technologies, such as High-Throughput Screening (HTS), Liquid Chromatography-Mass Spectrometry (LC-MS), and Next-generation Sequencing (NGS), have significantly enhanced the precision, speed, and sensitivity of bioanalytical testing. These innovations assist service providers in conducting more complex studies and gaining accurate data on drug efficacy, safety, and pharmacokinetics, among others. Moreover, integrating automation and Artificial Intelligence (AI) into bioanalytical workflows streamlined processes, reduced human error, and improved throughput. Such factors are anticipated to drive the market over the estimated period.

U.S. Bioanalytical Testing Services Market Report Segmentation

This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. bioanalytical testing services market report based on molecule, test, workflow, and end-use:

  • Molecule Outlook (Revenue, USD Million, 2018 - 2030)
  • Small Molecule
  • Large Molecule
    • LC-MS Studies
    • Immunoassays
    • Pharmacokinetics (PK)
    • ADA Assay
    • Other immunoassays
    • Other Large Molecule Tests
  • Test Outlook (Revenue, USD Million, 2018 - 2030)
  • ADME
    • In-vivo
    • In-vitro
  • Pharmacokinetics (PK)
  • Pharmacodynamics (PD)
  • Bioavailability
  • Bioequivalence
  • Biomarker Testing
  • Cell-based Assay
  • Virology Testing
  • Other Tests
  • Workflow Outlook (Revenue, USD Million, 2018 - 2030)
  • Sample Collection and Preparation
    • Sample Collection, Handling and Storage
    • Protein Precipitation
    • Liquid-Liquid Extraction
    • Solid Phase Extraction
    • Others
  • Method Development and Validation
  • Sample Analysis
    • Hyphenated Technique
    • Chromatographic Technique
    • Electrophoresis
    • Ligand Binding Assay
    • Mass Spectrometry
    • Spectroscopic Techniques
    • Nuclear Magnetic Resonance (NMR)
    • Others
    • Genomic and Molecular Techniques
    • Polymerase Chain Reaction (PCR)
    • Next-Generation Sequencing (NGS)
    • Others
  • Other Processes
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Pharma & BioPharma Companies
  • CDMO
  • CRO
  • Others

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Molecule
    • 1.2.2. Test
    • 1.2.3. Workflow
    • 1.2.4. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Bioanalytical Testing Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Technological Advancements & Growing R&D Investments
      • 3.2.1.2. Regulatory Control and Increasing Awareness Regarding Bioanalytical Testing
      • 3.2.1.3. Expansion of Bioanalytical Testing Facilities
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Compliance Issues While Outsourcing
      • 3.2.2.2. Data Security Concerns
  • 3.3. Investments & Funding Perspective
  • 3.4. Clinical Trials Volume Analysis, (2024)
    • 3.4.1. Total Number Of Clinical Trials By Region (2024)
    • 3.4.2. Total Number Of Clinical Trials, By Phase (2024)
    • 3.4.3. Total Number Of Clinical Trials, By Study Design (2024)
    • 3.4.4. Total Number Of Clinical Trials, By Key Therapeutic Area (2024)
  • 3.5. Pricing Model Analysis
  • 3.6. Technology Landscape
  • 3.7. Regulatory Framework
  • 3.8. Market Analysis Tools
    • 3.8.1. Porter's Five Force Analysis
    • 3.8.2. PESTEL by SWOT Analysis
    • 3.8.3. COVID-19 Impact Analysis

Chapter 4. U.S. Bioanalytical Testing Services Market: Molecule Estimates & Trend Analysis

  • 4.1. U.S. Bioanalytical Testing Services Market, By Molecule: Segment Dashboard
  • 4.2. U.S. Bioanalytical Testing Services Market, By Molecule: Movement Analysis
  • 4.3. U.S. Bioanalytical Testing Services Market Estimates & Forecasts, By Molecule, 2018 - 2030 (USD Million)
  • 4.4. Small Molecule
    • 4.4.1. Small Molecule Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Large Molecule
    • 4.5.1. Large Molecule Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. LC-MS Studies
      • 4.5.2.1. LC-MS Studies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Immunoassays
      • 4.5.3.1. Immunoassays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.3.2. Pharmacokinetics (PK)
        • 4.5.3.2.1. Pharmacokinetics (PK) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.3.3. ADA Assay
        • 4.5.3.3.1. ADA Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.3.4. Other
        • 4.5.3.4.1. Other Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Other Large Molecule Tests
      • 4.5.4.1. Other Large Molecule Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Bioanalytical Testing Services Market: Test Estimates & Trend Analysis

  • 5.1. U.S. Bioanalytical Testing Services Market, By Test: Segment Dashboard
  • 5.2. U.S. Bioanalytical Testing Services Market, By Test: Movement Analysis
  • 5.3. U.S. Bioanalytical Testing Services Market Estimates & Forecasts, By Test, 2018 - 2030 (USD Million)
  • 5.4. ADME
    • 5.4.1. ADME Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. In-vivo
      • 5.4.2.1. In-vivo Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. In-vitro
      • 5.4.3.1. In-vitro Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Pharmacokinetics (PK)
    • 5.5.1. Pharmacokinetics (PK) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Pharmacodynamics (PD)
    • 5.6.1. Pharmacodynamics (PD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Bioavailability
    • 5.7.1. Bioavailability Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Bioequivalence
    • 5.8.1. Bioequivalence Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Biomarker Testing
    • 5.9.1. Biomarker Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.10. Cell-based Assay
    • 5.10.1. Cell-based Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.11. Virology Testing
    • 5.11.1. Virology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.12. Other Tests
    • 5.12.1. Other Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Bioanalytical Testing Services Market: Workflow Estimates & Trend Analysis

  • 6.1. U.S. Bioanalytical Testing Services Market, By Workflow: Segment Dashboard
  • 6.2. U.S. Bioanalytical Testing Services Market, By Workflow Movement Analysis
  • 6.3. U.S. Bioanalytical Testing Services Market Estimates & Forecasts, By Workflow, 2018 - 2030 (USD Million)
  • 6.4. Sample Collection and Preparation
    • 6.4.1. Sample Collection and Preparation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Sample Collection, Handling and Storage
      • 6.4.2.1. Sample Collection, Handling and Storage Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Protein Precipitation
      • 6.4.3.1. Protein Precipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Liquid-Liquid Extraction
      • 6.4.4.1. Liquid-Liquid Extraction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Solid Phase Extraction
      • 6.4.5.1. Solid Phase Extraction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Others
      • 6.4.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Method Development and Validation
    • 6.5.1. Method Development and Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Sample Analysis
    • 6.6.1. Sample Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Hyphenated Technique
      • 6.6.2.1. Hyphenated Technique Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Chromatographic technique
      • 6.6.3.1. Chromatographic Technique Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. Electrophoresis
      • 6.6.4.1. Electrophoresis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Ligand Binding Assay
      • 6.6.5.1. Ligand Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Mass Spectrometry
      • 6.6.6.1. Mass Spectrometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Spectroscopic Techniques
      • 6.6.7.1. Spectroscopic Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.6.7.2. Nuclear Magnetic Resonance (NMR)
        • 6.6.7.2.1. Nuclear Magnetic Resonance (NMR) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.6.7.3. Others
        • 6.6.7.3.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.8. Genomic and Molecular Techniques
      • 6.6.8.1. Genomic and Molecular Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.6.8.2. Polymerase Chain Reaction (PCR)
        • 6.6.8.2.1. Polymerase Chain Reaction (PCR) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.6.8.3. Next-Generation Sequencing (NGS)
        • 6.6.8.3.1. Next-Generation Sequencing (NGS) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.6.8.4. Others
        • 6.6.8.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Other Processes
    • 6.7.1. Other Processes Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Bioanalytical Testing Services Market: End Use Estimates & Trend Analysis

  • 7.1. U.S. Bioanalytical Testing Services Market, By End Use: Segment Dashboard
  • 7.2. U.S. Bioanalytical Testing Services Market, By End Use: Movement Analysis
  • 7.3. U.S. Bioanalytical Testing Services Market Estimates & Forecasts, By End Use, 2018 - 2030 (USD Million)
  • 7.4. Pharma & BioPharma Companies
    • 7.4.1. Pharma & BioPharma Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. CDMO
    • 7.5.1. CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. CRO
    • 7.6.1. CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Company Market Share/Assessment Analysis, 2024
  • 8.3. Company Profiles
    • 8.3.1. Thermo Fisher Scientific, Inc.
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Service Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. ICON plc
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Service Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Charles River Laboratories International, Inc.
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Service Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Laboratory Corporation of America Holdings.
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. IQVIA Inc.
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Syneos Health
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Service Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. SGS SA
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Service Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Intertek Group Plc
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Service Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Pace Analytical Services, LLC
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Service Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. Medpace Holdings, Inc.
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Service Benchmarking
      • 8.3.10.4. Strategic Initiatives
    • 8.3.11. North America Science Associates Inc. (NAMSA)
      • 8.3.11.1. Company Overview
      • 8.3.11.2. Financial Performance
      • 8.3.11.3. Service Benchmarking
      • 8.3.11.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by Molecule, 2018 - 2030 (USD Million)
  • Table 3 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by Large Molecule Tests, 2018 - 2030 (USD Million)
  • Table 4 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by Large Molecule Immunoassay Tests, 2018 - 2030 (USD Million)
  • Table 5 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by Test, 2018 - 2030 (USD Million)
  • Table 6 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by ADME Test, 2018 - 2030 (USD Million)
  • Table 7 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 8 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by Sample Collection and Preparation, 2018 - 2030 (USD Million)
  • Table 9 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by Sample Analysis, 2018 - 2030 (USD Million)
  • Table 10 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by Spectroscopic Techniques, 2018 - 2030 (USD Million)
  • Table 11 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by Genomic and Molecular Techniques, 2018 - 2030 (USD Million)
  • Table 12 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 13 Financial performance

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2024 (USD Billion)
  • Fig. 16 U.S. Bioanalytical Testing Services Market dynamics
  • Fig. 17 Porter's Five Forces Analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 U.S. Bioanalytical Testing Services Market: Molecule Outlook and Key Takeaways
  • Fig. 20 U.S. Bioanalytical Testing Services Market: Molecule Movement Analysis
  • Fig. 21 Small Molecule Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Large Molecule Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 LC-MS Studies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Immunoassays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Pharmacokinetics (PK) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 ADA Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Other Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Other Large Molecule Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. Bioanalytical Testing Services Market: Test Outlook and Key Takeaways
  • Fig. 30 U.S. Bioanalytical Testing Services Market: Test Movement Analysis
  • Fig. 31 ADME Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 In-vivo Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 In-vitro Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Pharmacokinetics (PK) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Pharmacodynamics (PD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Bioavailability Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Bioequivalence Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Biomarker Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Cell-based Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Virology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Other Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. Bioanalytical Testing Services Market: Workflow Outlook and Key Takeaways
  • Fig. 43 U.S. Bioanalytical Testing Services Market: Workflow Movement Analysis
  • Fig. 44 Sample Collection and Preparation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Sample Collection, Handling and Storage Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Protein Precipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Liquid-Liquid Extraction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Solid Phase Extraction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Method Development and Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Sample Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Hyphenated technique Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Chromatographic technique Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Electrophoresis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Ligand Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Mass Spectrometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Spectroscopic Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Nuclear Magnetic Resonance (NMR) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Genomic and Molecular Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Polymerase Chain Reaction (PCR) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Next-Generation Sequencing (NGS) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Other Processes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 U.S. Bioanalytical Testing Services Market: End Use outlook and key takeaways
  • Fig. 66 U.S. Bioanalytical Testing Services Market: End Use movement analysis
  • Fig. 67 Pharma & BioPharma Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Key company categorization
  • Fig. 72 Service heat map analysis
  • Fig. 73 Strategic framework